228 related articles for article (PubMed ID: 21998749)
1. Apolipoprotein J/Clusterin is a novel structural component of human erythrocytes and a biomarker of cellular stress and senescence.
Antonelou MH; Kriebardis AG; Stamoulis KE; Trougakos IP; Papassideri IS
PLoS One; 2011; 6(10):e26032. PubMed ID: 21998749
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein J/clusterin in human erythrocytes is involved in the molecular process of defected material disposal during vesiculation.
Antonelou MH; Kriebardis AG; Stamoulis KE; Trougakos IP; Papassideri IS
PLoS One; 2011; 6(10):e26033. PubMed ID: 22016805
[TBL] [Abstract][Full Text] [Related]
3. ATM regulates insulin-like growth factor 1-secretory clusterin (IGF-1-sCLU) expression that protects cells against senescence.
Luo X; Suzuki M; Ghandhi SA; Amundson SA; Boothman DA
PLoS One; 2014; 9(6):e99983. PubMed ID: 24937130
[TBL] [Abstract][Full Text] [Related]
4. The chaperone activity of clusterin is dependent on glycosylation and redox environment.
Rohne P; Prochnow H; Wolf S; Renner B; Koch-Brandt C
Cell Physiol Biochem; 2014; 34(5):1626-39. PubMed ID: 25402950
[TBL] [Abstract][Full Text] [Related]
5. Intracellular clusterin inhibits mitochondrial apoptosis by suppressing p53-activating stress signals and stabilizing the cytosolic Ku70-Bax protein complex.
Trougakos IP; Lourda M; Antonelou MH; Kletsas D; Gorgoulis VG; Papassideri IS; Zou Y; Margaritis LH; Boothman DA; Gonos ES
Clin Cancer Res; 2009 Jan; 15(1):48-59. PubMed ID: 19118032
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress-associated shape transformation and membrane proteome remodeling in erythrocytes of end stage renal disease patients on hemodialysis.
Antonelou MH; Kriebardis AG; Velentzas AD; Kokkalis AC; Georgakopoulou SC; Papassideri IS
J Proteomics; 2011 Oct; 74(11):2441-52. PubMed ID: 21515423
[TBL] [Abstract][Full Text] [Related]
7. Markers of oxidative stress in senescent erythrocytes obtained from young and old age rats.
Kumar D; Rizvi SI
Rejuvenation Res; 2014 Oct; 17(5):446-52. PubMed ID: 25065263
[TBL] [Abstract][Full Text] [Related]
8. sCLU as prognostic biomarker and therapeutic target in osteosarcoma.
Ma J; Gao W; Gao J
Bioengineered; 2019 Dec; 10(1):229-239. PubMed ID: 31117872
[TBL] [Abstract][Full Text] [Related]
9. The molecular chaperone apolipoprotein J/clusterin as a sensor of oxidative stress: implications in therapeutic approaches - a mini-review.
Trougakos IP
Gerontology; 2013; 59(6):514-23. PubMed ID: 23689375
[TBL] [Abstract][Full Text] [Related]
10. Transcriptomes of Clusterin- and S100B-transfected neuronal cells elucidate protective mechanisms against hypoxia and oxidative stress in the hooded seal (Cystophora cristata) brain.
Martens GA; Geßner C; Osterhof C; Hankeln T; Burmester T
BMC Neurosci; 2022 Oct; 23(1):59. PubMed ID: 36243678
[TBL] [Abstract][Full Text] [Related]
11. Secretory clusterin promotes oral cancer cell survival via inhibiting apoptosis by activation of autophagy in AMPK/mTOR/ULK1 dependent pathway.
Naik PP; Mukhopadhyay S; Praharaj PP; Bhol CS; Panigrahi DP; Mahapatra KK; Patra S; Saha S; Panda AK; Panda K; Paul S; Aich P; Patra SK; Bhutia SK
Life Sci; 2021 Jan; 264():118722. PubMed ID: 33160989
[TBL] [Abstract][Full Text] [Related]
12. The therapeutic and prognostic role of clusterin in diverse musculoskeletal diseases: a mini review.
Zhang K; Liu K; Yu D; Tang Y; Geng B; Xia Y; Xu P
Physiol Res; 2022 Dec; 71(6):739-747. PubMed ID: 36281729
[TBL] [Abstract][Full Text] [Related]
13. Ex Vivo Activation of Red Blood Cell Senescence by Plasma from Sickle-Cell Disease Patients: Correlation between Markers and Adhesion Consequences during Acute Disease Events.
Chadebech P; Bodivit G; Di Liberto G; Jouard A; Vasseur C; Pirenne F; Bartolucci P
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34208829
[TBL] [Abstract][Full Text] [Related]
14. Increased expression levels of apolipoprotein J/clusterin during primary osteoarthritis.
Fandridis E; Apergis G; Korres DS; Nikolopoulos K; Zoubos AB; Papassideri I; Trougakos IP
In Vivo; 2011; 25(5):745-9. PubMed ID: 21753128
[TBL] [Abstract][Full Text] [Related]
15. Inborn defects in the antioxidant systems of human red blood cells.
van Zwieten R; Verhoeven AJ; Roos D
Free Radic Biol Med; 2014 Feb; 67():377-86. PubMed ID: 24316370
[TBL] [Abstract][Full Text] [Related]
16. Clusterin, a Novel DEC1 Target, Modulates DNA Damage-Mediated Cell Death.
Ming X; Bao C; Hong T; Yang Y; Chen X; Jung YS; Qian Y
Mol Cancer Res; 2018 Nov; 16(11):1641-1651. PubMed ID: 30002194
[TBL] [Abstract][Full Text] [Related]
17. Novel nucleolar localization of clusterin and its associated functions in human oral cancers: An in vitro and in silico analysis.
Kadam R; Harish M; Dalvi K; Teni T
Cell Biochem Funct; 2021 Apr; 39(3):380-391. PubMed ID: 33155695
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression levels of the senescence biomarker clusterin/apolipoprotein j in lymphocytes from healthy centenarians.
Trougakos IP; Petropoulou C; Franceschi C; Gonos ES
Ann N Y Acad Sci; 2006 May; 1067():294-300. PubMed ID: 16804001
[TBL] [Abstract][Full Text] [Related]
19. Golgi phosphoprotein 2 (GOLPH2/GP73/GOLM1) interacts with secretory clusterin.
Zhou Y; Li L; Hu L; Peng T
Mol Biol Rep; 2011 Mar; 38(3):1457-62. PubMed ID: 20842452
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of secretory clusterin (sCLU) induces chemotherapy resistance in human gastric cancer cells by targeting miR-195-5p.
Mu L; Yang F; Guo D; Li P; Zhang M
Bioengineered; 2020 Dec; 11(1):472-483. PubMed ID: 32250192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
